Omnimmune Holdings, Inc. Stock Other OTC
Equities
OMMH
US68216A1043
Biotechnology & Medical Research
Financials (USD)
Sales 2008 | - | Sales 2009 | - | Capitalization | 1.43M |
---|---|---|---|---|---|
Net income 2008 | -5M | Net income 2009 | -1M | EV / Sales 2008 | - |
Net Debt 2008 | 2.3M | Net Debt 2009 | 2.58M | EV / Sales 2009 | - |
P/E ratio 2008 |
-0.55
x | P/E ratio 2009 |
-0.8
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 42.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | - |
1st Jan change | Capi. | |
---|---|---|
+3.36% | 42.11B | |
+48.83% | 40.08B | |
+8.38% | 40B | |
-10.82% | 26.87B | |
+8.24% | 24.58B | |
-23.29% | 18.44B | |
+1.61% | 11.94B | |
+33.22% | 11.66B | |
+7.12% | 11.01B |